litlas
ログインアカウント作成

Stephen K. Tyring

1992–2025 年に発表

148
論文数
24,673
被引用数
90
h 指数
143
i10 指数

被引用数

Stephen K. Tyring の年別被引用数1986 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 7 件1994 年: 被引用 6 件1995 年: 被引用 10 件1996 年: 被引用 34 件1997 年: 被引用 40 件1998 年: 被引用 27 件1999 年: 被引用 47 件2000 年: 被引用 54 件2001 年: 被引用 62 件2002 年: 被引用 94 件2003 年: 被引用 85 件2004 年: 被引用 101 件2005 年: 被引用 115 件2006 年: 被引用 125 件2007 年: 被引用 162 件2008 年: 被引用 160 件2009 年: 被引用 137 件2010 年: 被引用 141 件2011 年: 被引用 152 件2012 年: 被引用 152 件2013 年: 被引用 153 件2014 年: 被引用 140 件2015 年: 被引用 160 件2016 年: 被引用 204 件2017 年: 被引用 243 件2018 年: 被引用 258 件2019 年: 被引用 735 件2020 年: 被引用 701 件2021 年: 被引用 648 件2022 年: 被引用 450 件2023 年: 被引用 402 件2024 年: 被引用 563 件2025 年: 被引用 301 件2026 年: 被引用 2 件1987〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,318 件、この内訳の 28.2%イギリス: 引用元論文 611 件、この内訳の 7.4%ドイツ: 引用元論文 592 件、この内訳の 7.2%カナダ: 引用元論文 459 件、この内訳の 5.6%中国: 引用元論文 409 件、この内訳の 5%イタリア: 引用元論文 404 件、この内訳の 4.9%フランス: 引用元論文 307 件、この内訳の 3.7%スイス: 引用元論文 249 件、この内訳の 3%スペイン: 引用元論文 246 件、この内訳の 3%日本: 引用元論文 208 件、この内訳の 2.5%オーストラリア: 引用元論文 202 件、この内訳の 2.5%オランダ: 引用元論文 195 件、この内訳の 2.4%
0%28.2%その他 24.6%

機関

分野

  • Medicine52%
  • Immunology and Microbiology32.2%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Neuroscience5.6%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Psychology0.4%
  • その他1.9%

トピック

  • Psoriasis: Treatment and Pathogenesis10.8%
  • Dermatology and Skin Diseases6.9%
  • Spondyloarthritis Studies and Treatments4.9%
  • Herpesvirus Infections and Treatments4.4%
  • Cytomegalovirus and herpesvirus research2.7%
  • Cervical Cancer and HPV Research2.2%
  • その他68.1%

共著者

全論文

検索で開く
  1. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

    著者: Richard G. Langley, Boni E. Elewski, Mark Lebwohl, Kristian Reich, C.E.M. Griffiths, Kim Papp, L. Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson, Enrique Rivas, Tsen‐Fang Tsai, Norman Wasel, Stephen K. Tyring, Thomas Salko, Isabelle Hampele, Marianne Notter, Alexander Karpov, Silvia Helou, C. Papavassilis - New England Journal of Medicine 2014 被引用: 1,964

  2. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

    著者: Kristian Reich, Kim Papp, Andrew Blauvelt, Stephen K. Tyring, Rodney Sinclair, Diamant Thaçi, Kristine Nograles, Anish Mehta, N. Cichanowitz, Qing Li, Kenneth Liu, Carmen La Rosa, Stuart Green, Alexa B. Kimball - The Lancet 2017 被引用: 556

  3. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    著者: Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula - New England Journal of Medicine 2015 被引用: 806

  4. Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

    著者: Kim Papp, Andrew Blauvelt, Michael Bukhalo, Melinda Gooderham, James G. Krueger, J.‐P. Lacour, Alan Menter, Sandra Philipp, Howard Sofen, Stephen K. Tyring, B Berner, Sudha Visvanathan, Chandrasena Pamulapati, Nathan Bennett, Mary Flack, Paul Scholl, Steven J. Padula - New England Journal of Medicine 2017 被引用: 511

  5. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    著者: Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, Ken Gordon, Craig L. Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik, David Cella, Ranga Krishnan - The Lancet 2005 被引用: 1,069

  6. Recommendations for the Management of Herpes Zoster

    著者: Robert H. Dworkin, Robert W. Johnson, Judith Breuer, John W. Gnann, Myron J. Levin, Miroslav Bačkonja, Robert F. Betts, Anne A. Gershon, Maija Haanpää, Michael W. McKendrick, Turo Nurmikko, Anne Louise Oaklander, Michael N. Oxman, Deborah Pavan Langston, Karin L. Petersen, Michael C. Rowbotham, Kenneth E. Schmader, Brett R. Stacey, Stephen K. Tyring, Albert J. M. van Wijck, Mark S. Wallace, Sawko W. Wassilew, Richard J. Whitley - Clinical Infectious Diseases 2006 被引用: 845

  7. One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial

    著者: Bruce Strober, Linda Stein Gold, Robert Bissonnette, April W. Armstrong, Leon Kircik, Stephen K. Tyring, Stephen C. Piscitelli, Philip M. Brown, David S. Rubenstein, Anna M. Tallman, Mark Lebwohl - Journal of the American Academy of Dermatology 2022 被引用: 88

  8. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

    著者: Andrew Blauvelt, Kim Papp, Alice B. Gottlieb, Abel Jarell, Kristian Reich, Catherine Maari, Kenneth B. Gordon, Laura K. Ferris, Richard G. Langley, Yayoi Tada, Renata Gontijo Lima, Hany Elmaraghy, Gaia Gallo, L. Renda, S‐M. Park, Russel Burge, Jerry Bagel, the IXORA‐R Study Group, Ronald Vender, Mark Lomaga, Isabelle Delorme, Chih-ho Hong, Richard L. Langley, Lorne Albrecht, Lyn Guenther, Catherine Maari, Kim Papp, Kamal Ohson, Kirk Barber, Charles Lynde, Aditya Gupta, Leslie Rosoph, Jean‐Sébastien Gauthier, Melinda Gooderham, Norman Wasel, Mani Raman, Marni Wiseman, David Greenstein, Abel Jarell, C. A. L. Moon, Lani Clark, S. Jazayeri, Michael Bukhalo, Angela Moore, Tiffani K. Hamilton, Aron Gewirtzman, Lydie Hazan, Jeffrey Crowley, Craig Teller, Matthew Zirwas, Stacy Smith, Mark Lee, Stephen K. Tyring, Patricia Lee, Sunil Dhawan, Craig L. Leonardi, Amarilis Perez‐De Jesus, Wendy McFalda, Ellen Frankel, Paul S. Yamauchi, Scott Fretzin, Rocco Serrao, Todd Schlesinger, Scott Gottlieb, Peter Jenkin, Rola Gharib, Steven A. Davis, Navid Nami, Zoe Diana Draelos, Lloyd Godwin, Cindy E. Owen, Megan N. Landis, William Abramovits, Samuel Sanchez‐Rivera, Abby Van Voorhees, David Fivenson, Francisco A. Kerdel, Seth Forman, Jeffrey S. Weinberg, José González-Chávez, Brent Boyce, Linda Stein‐Gold, Charles P. Hudson, Constance Brown, James Coggi, Christina Feser, Rion Forconi, Sandra Johnson, Mark McCune, Lawrence Green, Vandana Madkan, Dana Maxwell Shipp, Kenneth B. Gordon, Jill Waibel, Oscar Soto‐Raices, Jennifer Cather, Scott Miller, John P. Scott, Douglas Young, Jessica Kaffenberger ほか 42 名 - British Journal of Dermatology 2019 被引用: 172

  9. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

    著者: Howard Sofen, Robert Bissonnette, Gil Yosipovitch, Jonathan I. Silverberg, Stephen K. Tyring, Wei Jing Loo, Matthew Zook, Mark Lee, Liangxing Zou, Guang-Liang Jiang, John F. Paolini - EClinicalMedicine 2023 被引用: 99

  10. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

    著者: Andrew Blauvelt, Steven Kempers, Edward Lain, Todd Schlesinger, Stephen K. Tyring, Seth Forman, Glynis Ablon, George M. Martin, Hui Wang, David L. Cutler, Jane Fang, Min-Fun Rudolf Kwan - New England Journal of Medicine 2021 被引用: 161

  11. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers

    著者: Nehal N. Mehta, Daniel B. Shin, Aditya A. Joshi, Amit K. Dey, April W. Armstrong, Kristina Callis Duffin, Zelma C. Chiesa Fuxench, Charlotte Harrington, Rebecca A. Hubbard, Robert E. Kalb, Alan Menter, Daniel J. Rader, Muredach P. Reilly, Eric L. Simpson, Junko Takeshita, Drew A. Torigian, Thomas Werner, Andrea B. Troxel, Stephen K. Tyring, Suzette Báez Vanderbeek, Abby S. Van Voorhees, Martin P. Playford, Mark A. Ahlman, Abass Alavi, Joel M. Gelfand - Circulation Cardiovascular Imaging 2018 被引用: 147

  12. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    著者: Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp - Journal of the American Academy of Dermatology 2007 被引用: 883

  13. Viral Oncology: Molecular Biology and Pathogenesis

    著者: Uyen Ngoc Mui, Christopher T. Haley, Stephen K. Tyring - Journal of Clinical Medicine 2017 被引用: 221

  14. Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis

    著者: Joel M. Gelfand, Daniel B. Shin, April W. Armstrong, Stephen K. Tyring, Andrew Blauvelt, Scott Gottlieb, Benjamin Lockshin, Robert E. Kalb, Robert Fitzsimmons, Justin Rodante, Philip M. Parel, Grigory A. Manyak, Laurel Mendelsohn, Megan H. Noe, Maryte Papadopoulos, Maha N. Syed, Thomas Werner, Joy Wan, Martin P. Playford, Abass Alavi, Nehal N. Mehta - JAMA Dermatology 2022 被引用: 44

  15. Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

    著者: Andrew Blauvelt, Eric L. Simpson, Stephen K. Tyring, Lisa A. Purcell, Brad Shumel, Christopher D. Petro, Bolanle Akinlade, Abhijit Gadkari, Laurent Eckert, Neil M.H. Graham, Gianluca Pirozzi, Robert R. Evans - Journal of the American Academy of Dermatology 2018 被引用: 137

  16. A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)

    著者: Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April Armstrong, Andrew Blauvelt, Stephen K. Tyring, Alan Menter, Scott Gottlieb, Benjamin Lockshin, Eric L. Simpson, Farid Kianifard, R. Sarkar, Elisa Muscianisi, Jennifer Steadman, Mark A. Ahlman, Martin P. Playford, Aditya A. Joshi, Amit K. Dey, Thomas Werner, Abass Alavi, Nehal N. Mehta - Journal of Investigative Dermatology 2020 被引用: 95

  17. Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise.

    著者: Brooks David Kimmis, Christopher Downing, Stephen K. Tyring - 2018 被引用: 109

  18. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

    著者: Kim Papp, Stephen K. Tyring, M. Lahfa, Jörg C. Prinz, C.E.M. Griffiths, Arline Nakanishi, Ralph Zitnik, P.C.M. van de Kerkhof, the Etanercept Psoriasis Study Group - British Journal of Dermatology 2005 被引用: 692

  19. Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

    著者: Lawrence Corey, Anna Wald, Raj Patel, Stephen L. Sacks, Stephen K. Tyring, Terri Warren, John M. Douglas, Jorma Paavonen, Rhoda Ashley Morrow, Karl R. Beutner, Leonid S. Stratchounsky, Grégory Mertz, Oliver N. Keene, Helen Watson, Dereck Tait, Mauricio Vargas‐Cortes - New England Journal of Medicine 2003 被引用: 727

  20. Hailey–Hailey disease treated with dupilumab: a case series

    著者: Nujood Alzahrani, J. Grossman‐Kranseler, Ritu Swali, Kristin Fiumara, Pedro Zancanaro, Stephen K. Tyring, David Rosmarin - British Journal of Dermatology 2021 被引用: 55

  21. Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis

    著者: Stephen K. Tyring, Kenneth B. Gordon, Yves Poulin, Richard G. Langley, Alice B. Gottlieb, M. Dunn, Angelika Jahreis - Archives of Dermatology 2007 被引用: 321

  22. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

    著者: Andrew Blauvelt, Kristian Reich, Tsen‐Fang Tsai, Stephen K. Tyring, F. Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Ronald Vender, Sophie Hugot, R. You, M. Milutinovic, Diamant Thaçi - Journal of the American Academy of Dermatology 2016 被引用: 304

  23. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

    著者: Kim Papp, James G. Krueger, Steven R. Feldman, Richard G. Langley, Diamant Thaçi, Hideshi Torii, Stephen K. Tyring, Robert Wołk, Annie Gardner, Charles A. Mebus, Huaming Tan, Yingchun Luo, Pankaj Gupta, Lotus Mallbris, Svitlana Tatulych - Journal of the American Academy of Dermatology 2016 被引用: 155

  24. The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study

    著者: Robert Bissonnette, Catherine Maari, Seth Forman, Neal Bhatia, M. Lee, Joseph F. Fowler, Stephen K. Tyring, David M. Pariser, Howard Sofen, Sunil Dhawan, M. Zook, David J. Zammit, Helen Usansky, L. Denis, Niranjan Rao, Teresa Song, Ana B. Pavel, Emma Guttman‐Yassky - British Journal of Dermatology 2019 被引用: 129